OsteoRemedies

OsteoRemedies is a privately held company based in Memphis, Tennessee. The company employs 28 people and has reported annual revenue of $11 million. OsteoRemedies specializes in developing innovative solutions for complex medical issues, particularly in the field of revision and infection remedies related to joint replacement. OsteoRemedies offers a range of products designed for surgeons treating two-stage revision of infected total joints. Their flagship product line is the REMEDY SPECTRUM® GV Hip System and SPECTRUM® GV Bone Cement, a first-of-its-kind broad-spectrum treatment option incorporating both Gentamicin and Vancomycin. Complementing this, they also provide the REMEDY® Spacer System, a unique pre-molded modular spacer system designed for use in hip, knee, and shoulder replacements. Additionally, OsteoRemedies offers the OSTEOBOOST® Select™ Resorbable Bead Kit, a tri-phasic bone void filler available in a convenient bead kit formulation. OsteoRemedies distinguishes itself through its commitment to providing innovative, first-to-market products. The company emphasizes its lean and adaptable business model, enabling it to deliver exceptional returns to its stakeholders while maintaining strict ethical and regulatory compliance. For more information about OsteoRemedies and its products, visit their website at osteoremedies.com.